This archive collects solutions-journalism stories and milestones from Kenya — covering health, education, environment, technology, and community-led progress. Each entry highlights real efforts and measurable outcomes shaping life across the country.
Nzambi Matee’s Nairobi-based company, Gjenge Makers, produces a variety of different paving stones, which are already being put to use to line sidewalks, driveways, and roads.
The African Court of Human and Peoples’ Rights has ruled that the Kenyan government must pay reparations for repeatedly evicting Indigenous Ogiek people from ancestral lands in the Mau Forest.
The crucial resolution will help develop a better understanding of the relationship between improving animal welfare and tackling the drivers of wildlife loss, climate change, pollution and pandemic diseases.
The measure calls for an international negotiating committee to set the terms of a treaty on plastic pollution by the end of 2024.
Farmers are learning how to make their degraded lands productive again after joining DryDev, a project led by World Agroforestry that has been working with farmers in Kenya, Burkina Faso, Ethiopia, Mali and Niger since 2013.
2020 was remarkable year for rhino protection in Kenya where not one single rhino lost its horn or lost its life last year—a feat not achieved since 1999.
Google parent company Alphabet’s internet-beaming Project Loon balloons have taken on their first commercial task. The high-flying communications aircraft are now providing thousands of Kenyans with internet access.
The researchers are now investigating whether they can release infected mosquitoes into the wild, or use spores to suppress the disease, in order to reduce the incidence of the disease among humans.
A Kenyan startup, Opibus, is forging ahead with its plans to electrify old Matatus and Boda Bodas. Opibus begins mass EV conversions of minibuses and motorcycles in Q1 2020.
Malaria research has taken a genuinely hopeful turn, with Kenyan scientists at KEMRI identifying a bacterial derivative that kills Plasmodium falciparum through a mechanism the parasite hasn’t yet learned to resist — a critical advantage as drug resistance spreads. Building on earlier trials showing ivermectin-treated patients had blood lethal to mosquitoes, this research opens a new line of attack, originated by African scientists and designed around pregnant women and children from the start. Human trials still lie ahead, and that path is long — but the science points toward tools the world urgently needs.
